Niagen Bioscience, Inc. (NAGE) has 10 SEC Form 4 insider filings on record in the last 90 days. Most recent filing: July 8, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| July 8, 2026 filed June 30, 2026 | Lopez Carlos Luis SVP, General Counsel | $6,271 | 2,314 | +103% | No | |
|
|
||||||
| July 8, 2026 filed June 30, 2026 | Pamir Ozan Chief Financial Officer | $11,531 | 4,255 | +58% | No | |
|
|
||||||
| July 8, 2026 filed June 30, 2026 | Fried Robert N Chief Executive Officer | $2,997 | 1,106 | +0% | No | |
|
|
||||||
| June 26, 2026 filed June 24, 2026 | YU Wing Tak Wendy Director | $0 | 31,746 | 0% | No | |
|
|
||||||
| June 26, 2026 filed June 24, 2026 | Ng Wang Yu Gary Director | $0 | 31,746 | 0% | No | |
|
|
||||||
Showing the 5 most recent of 10 filings in the last 90 days.
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free